<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28369393</article-id>
<article-id pub-id-type="pmc">6075076</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddx108</article-id>
<article-id pub-id-type="publisher-id">ddx108</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Selective rescue of heightened anxiety but not gait ataxia in a premutation 90CGG mouse model of Fragile X-associated tremor/ataxia syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Castro</surname>
<given-names>Hoanna</given-names>
</name>
<xref ref-type="aff" rid="ddx108-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kul</surname>
<given-names>Emre</given-names>
</name>
<xref ref-type="aff" rid="ddx108-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buijsen</surname>
<given-names>Ronald A.M.</given-names>
</name>
<xref ref-type="aff" rid="ddx108-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Severijnen</surname>
<given-names>Lies-Anne W.F.M.</given-names>
</name>
<xref ref-type="aff" rid="ddx108-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Willemsen</surname>
<given-names>Rob</given-names>
</name>
<xref ref-type="aff" rid="ddx108-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hukema</surname>
<given-names>Renate K.</given-names>
</name>
<xref ref-type="aff" rid="ddx108-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stork</surname>
<given-names>Oliver</given-names>
</name>
<xref ref-type="aff" rid="ddx108-aff1">1</xref>
<xref ref-type="aff" rid="ddx108-aff3">3</xref>
<xref ref-type="corresp" rid="ddx108-FM1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santos</surname>
<given-names>Mónica</given-names>
</name>
<xref ref-type="aff" rid="ddx108-aff1">1</xref>
<xref ref-type="corresp" rid="ddx108-FM1"></xref>
<xref ref-type="corresp" rid="ddx108-cor1"></xref>
<!--<email>monica.santos@ovgu.de</email>-->
</contrib>
</contrib-group>
<aff id="ddx108-aff1">
<label>1</label>Department of Genetics and Molecular Neurobiology, Institute of Biology, Otto-von-Guericke University, 39120 Magdeburg, Germany,</aff>
<aff id="ddx108-aff2">
<label>2</label>Department of Clinical Genetics, Erasmus MC, 3000 CA Rotterdam, The Netherlands</aff>
<aff id="ddx108-aff3">
<label>3</label>Center for Behavioral Brain Sciences, Magdeburg</aff>
<author-notes>
<corresp id="ddx108-cor1"><label>*</label>To whom correspondence should be addressed. Tel: +49 03916755108; Fax: +49 03916755102; Email: <email>monica.santos@ovgu.de</email>, <email>monicapsantos@hotmail.com</email></corresp>
<fn id="ddx108-FM1">
<p>
<sup>†</sup>The authors wish it to be known that, in their opinion, the last two authors should be regarded as joint Last Authors.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2017-03-22" pub-type="epub">
<day>22</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>26</volume>
<issue>11</issue>
<fpage>2133</fpage>
<lpage>2145</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>30</day>
<month>1</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>3</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="ddx108.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>A CGG-repeat expansion in the premutation range in the Fragile X mental retardation 1 gene (<italic>FMR1</italic>) has been identified as the genetic cause of Fragile X-associated tremor/ataxia syndrome (FXTAS), a late-onset neurodegenerative disorder that manifests with action tremor, gait ataxia and cognitive impairments. In this study, we used a bigenic mouse model, in which expression of a 90CGG premutation tract is activated in neural cells upon doxycycline administration—P90CGG mouse model. We, here, demonstrate the behavioural manifestation of clinically relevant features of FXTAS patients and premutation carrier individuals in this inducible mouse model. P90CGG mice display heightened anxiety, deficits in motor coordination and impaired gait and represent the first FXTAS model that exhibits an ataxia phenotype as observed in patients. The behavioural phenotype is accompanied by the formation of ubiquitin/FMRpolyglycine-positive intranuclear inclusions, as another hallmark of FXTAS, in the cerebellum, hippocampus and amygdala. Strikingly, upon cessation of transgene induction the anxiety phenotype of mice recovers along with a reduction of intranuclear inclusions in dentate gyrus and amygdala. In contrast, motor function deteriorates further and no reduction in intranuclear inclusions can be observed in the cerebellum. Our data thus demonstrate that expression of a 90CGG premutation expansion outside of the <italic>FMR1</italic> context is sufficient to evoke an FXTAS-like behavioural phenotype. Brain region-specific neuropathology and (partial) behavioural reversibility make the inducible P90CGG a valuable mouse model for testing pathogenic mechanisms and therapeutic intervention methods.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>NINDS RO1, NS079775</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">E-Rare-2 JTC 2012 and E-Rare-2 JTC 2014 by the German Federal Ministry of Education and Research (BMBF)</named-content>
</funding-source>
<award-id>01GM1302</award-id>
<award-id>01GM1505</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">ZonMw</named-content>
</funding-source>
<award-id>113301201</award-id>
<award-id>113301401</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Netherlands Brain Foundation</named-content>
</funding-source>
<award-id>F2012 (1)-101</award-id>
<award-id>F2015 (1)-02</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>